SCHEMBL2766044

SCHEMBL2766044

CCc1ccn(C(C)(n2ccc(CC)n2)n2ccc(CC)n2)n1.Cl[Mn]Cl

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.35
CYP4A11 Q02928 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2455142 0.92 CYP4F2 (0.39) CYP4F2CYP4A11
SCHEMBL2766523 0.86 CYP4F2 (0.40) CYP4F2CYP4A11
SCHEMBL2765752 0.83 CYP4F2 (0.44) CYP4F2CYP4A11
SCHEMBL2765475 0.81 CYP4F2 (0.31) CYP4F2CYP4A11
SCHEMBL17264246 0.80 CYP4F2 (0.39) CYP4F2CYP4A11
SCHEMBL17663279 0.75 CYP4F2 (0.35) CYP4F2CYP4A11
SCHEMBL2765815 0.74 CYP4F2 (0.33) CYP4F2CYP4A11
SCHEMBL22306522 0.74 CYP4F2 (0.41) CYP4F2CYP4A11
SCHEMBL2766298 0.73
SCHEMBL2765813 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1266911-B1 Catalyst for addition polymerization and process for producing an addition polymer SUMITOMO CHEMICAL CO (JP) 2010-04-14 EP disclosed
US-6881802-B2 Catalyst for addition polymerization and process for producing an addition polymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2005-04-19 US disclosed
US-20030032743-A1 Catalyst for addition polymerization and process for producing an addition polymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-02-13 US disclosed
EP-1266911-A1 Catalyst for addition polymerization and process for producing an addition polymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-12-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030032743-A1 Catalyst for addition polymerization and process for producing an addition polymer BRAP, MCM4, BOLA2; BOLA2B CYP4F2 1337/4885CYP4A11 871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.